Is early loss of minimal luminal diameter after successful PTCA prevented by c7E3 IIb/IIIa antiplatelet antibody?

被引：0

作者：

Leon, MN ^{[1
]}

Gold, HK ^{[1
]}

Mahdi, NA ^{[1
]}

Harrell, L ^{[1
]}

Rodriguez, A ^{[1
]}

Palacios, IF ^{[1
]}

机构：

[1] Massachusetts Gen Hosp, Boston, MA 02114 USA

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 1998年 / 31卷 / 02期

关键词：

D O I：

10.1016/S0735-1097(97)83945-9

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：55A / 55A

页数：1

共 49 条

[41] SAFETY AND ANTIPLATELET EFFECT OF MURINE MONOCLONAL-ANTIBODY 7E3 FAB DIRECTED AGAINST PLATELET GLYCOPROTEIN-IIB/IIIA IN PATIENTS UNDERGOING ELECTIVE CORONARY ANGIOPLASTY
ELLIS, SG
TCHENG, JE
NAVETTA, FI
MULLER, DWM
WEISMAN, HF
SMITH, C
ANDERSON, KM
CALIFF, RM
TOPOL, EJ
CORONARY ARTERY DISEASE, 1993, 4 (02) : 167 - 175
[42] Evidence for prevention of death and myocardial infarction with platelet membrane glycoprotein IIb/IIIa receptor blockade by abciximab (c7E3 Fab) among patients with unstable angina undergoing percutaneous coronary revascularization
Lincoff, AM
Califf, RM
Anderson, KM
Weisman, HF
Aguirre, FV
Kleiman, NS
Harrington, RA
Topol, EJ
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 30 (01) : 149 - 156
[43] Laboratory Monitoring of Heparin and the Combination of Heparin and the Platelet Glycoprotein IIb/IIIa Receptor Antibody Fragment Abciximab (c7E3) in Patients Undergoing Percutaneous Transluminal Coronary Angioplasty (PTCA)Labormonitoring der Heparintherapie und der kombinierten Gabe von Heparin und dem Glykoprotein-IIb/IIIa- Antagonisten Abciximab bei Patienten während einer perkutanen transluminalen koronaren Ballonangioplastie
Ralf Zahn
Hannelore Haubelt
Sabine Bechtloff
Steffen Schneider
Birgit Frilling
Jörg Rustige
Parvaneh Marsalek
Karlheinz Seidl
Jochen Senges
Peter Hellstern
Herz, 2003, 28 : 445 - 452
[44] Discovery of novel orally active non-peptide antiplatelet GPIIb/IIIa antagonist, DMP754: Comparative platelet binding affinity profiles with DMP728 and c7E3
Mousa, SA
Bozarth, J
Forsythe, M
Xue, CB
Wityak, J
Olson, R
Thoolen, M
Reilly, T
THROMBOSIS AND HAEMOSTASIS, 1997, : P2707 - P2707
[45] Dissociation between the anti-aggregatory & anti-secretory effects of platelet integrin αIIbβ3 (GPIIb/IIIa) antagonists, c7E3 and DMP728 (vol 88, pg 137, 1997)
Tsao, PW
Forsythe, MS
Mousa, SA
THROMBOSIS RESEARCH, 1998, 89 (02) : 97 - 97
[46] The GP IIb/IIIa inhibitor abciximab (c7E3) inhibits the binding of various ligands to the leukocyte integrin Mac-1 (CD11b/CD18, αMβ2)
Schwarz, M
Nordt, T
Bode, C
Peter, K
THROMBOSIS RESEARCH, 2002, 107 (3-4) : 121 - 128
[47] TIME-COURSE OF THE EFFECTS OF A SINGLE BOLUS INJECTION OF F(AB')2 FRAGMENTS OF THE ANTIPLATELET GLYCOPROTEIN-IIB/IIIA (GPIIB/IIIA) ANTIBODY-7E3, 7E3-F(AB')2, ON ARTERIAL EVERSION GRAFT OCCLUSION, PLATELET-AGGREGATION AND BLEEDING-TIME IN DOGS
KISS, RG
COLLEN, D
LU, HR
JANG, IK
ROSKAMS, T
PLOW, EF
GOLD, HK
THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 1322 - 1322
[48] ACCELERATION AND PERSISTENCE OF RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR INDUCED ARTERIAL EVERSION GRAFT RECANALIZATION WITH A SINGLE BOLUS INJECTION OF F(AB')2 FRAGMENTS OF THE ANTIPLATELET GLYCOPROTEIN IIB/IIIA ANTIBODY 7E3
LU, HR
GOLD, HK
WU, ZM
DECOCK, F
JANG, IK
PAUWELS, P
COLLEN, D
CORONARY ARTERY DISEASE, 1991, 2 (09) : 1039 - 1046
[49] C7E3 Fab inhibits low shear flow modulated platelet adhesion to endothelium and surface-adsorbed fibrinogen by blocking platelet GP IIb/IIIa as well as endothelial vitronectin receptor - Results from patients with acute myocardial infarction and healthy controls
Reininger, AJ
Agneskirchner, J
Bode, PA
Spannagl, M
Wurzinger, LJ
THROMBOSIS AND HAEMOSTASIS, 2000, 83 (02) : 217 - 223

← 1 2 3 4 5 →